Portfolio Manager/Sub-Investment Adviser
The fund's investment adviser is The Dreyfus Corporation (Dreyfus). Dreyfus has engaged its affiliate, The Boston Company Asset Management, LLC (TBCAM), to serve as the fund's sub-investment adviser. Investment decisions for the fund are made by members of TBCAM's global research team. The team members primarily responsible for managing the fund are Elizabeth Slover and Matthew D. Griffin, CFA, positions they have held since the fund's inception. Ms. Slover is a senior managing director at TBCAM, and is the director of TBCAM's global research team. Mr. Griffin is a managing director and portfolio manager at TBCAM, and is a member of TBCAM's global research team.
Dreyfus is permitted to use a manager of managers approach and select one or more sub-investment advisers to manage the fund's assets. Currently, Dreyfus has engaged TBCAM to manage all of the fund's assets. Dreyfus has ultimate responsibility (subject to oversight by the fund's board) to supervise any sub-investment adviser and recommend the hiring, termination, and replacement of any sub-investment adviser to the fund's board. The fund is required to provide shareholders with information about each new sub-investment adviser within 90 days of the hiring of any new sub investment adviser.
Top Holdings 2
|Amphenol, Cl. A||1.17%|
|Bank Of America||1.09%|
|Wells Fargo & Co.||1.03%|
|Bank Of Ireland||1.01%|
|Hartford Financial Services Group||0.99%|
|Royal Bank Of Scotland||0.99%|
|Number of Holdings||118
as of 12/31/14
|Portfolio Turnover Rate||204.65%
as of fiscal year end 10/31/14
|P/E Ratio 3||17.16
as of 12/31/15
Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or a summary prospectus, if available, that contains this and other information about the fund, and read it carefully before investing.
Notes & Disclosures
- Portfolio composition and allocation is as of 12/31/14 and is subject to change at any time. Totals may not be exact due to rounding. Negative exposures may represent short positions through derivatives.
- The holdings listed should not be considered recommendations to buy or sell a security. Large concentrations can increase share price volatility.
- Price/earnings for a stock is the ratio of the company's most recent month-end share price to the company's estimated earnings per share (EPS) for the current fiscal year. If a third-party estimate for the current year EPS is not available, Morningstar will calculate an internal estimate based on the most recently reported EPS and average historical earnings growth rates. Price/ earnings is one of the five value factors used to calculate the Morningstar Style Box. For portfolios, this historical P/E data point is calculated by taking an asset-weighted average of the earnings yields (E/P) of all the stocks in the portfolio and then taking the reciprocal of the result. Source: Morningstar